Idex Corporation · NYSE:IEX
Idex — Investor Presentation (March 2026)
26 slides from Idex's investor presentation, March 2026
Slide 1: Investor Overview
Investor Overview March 2026 1
Slide 2: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward
Slide 3: About IDEX
EEX About IDEX
Slide 4: IDEX at a Glance
IDEX at a Glance FSDP Global engineered products company focused 22% on delivering mission critical solutions, pivoting towards higher growth, specialized markets Sales by 43% HST ~8,700 Segment* EMPLOYEES Well-positioned with proprietary, specialized technologies across a diverse set of markets 3
Slide 5: IDEX Value Drivers
IDEX Value Drivers Differentiated 8020 operating model drives full business potential through simplification, focused resourcing and streamlined execution Focused on continuously evolving our portfolio toward high-growth, advantaged markets with secular tailwinds Disciplined capital allocation with
Slide 6: 8020 Culture Drives Sustainable Growth and Value Creation
8020 Culture Drives Sustainable Growth and Value Creation Solving critical engineering needs Operational Excellence Removing complexity to drive efficient operations Empowering our teams to serve customers with speed and agility Segmenting and prioritizing high-value customers Focusing sal
Slide 7: The Purposeful Evolution of IDEX
The Purposeful Evolution of IDEX $3.5B 2 0 2 5 R E V E N U E S Staging sustainable value creation in Phase III PHASE III P AT H T O H I G H E R GROWTH WITH 8020 1) Targeting higher-growth, advantaged markets PHASE II OPTIMIZED WITH 8020 2) Accelerating commercial Introduced 8020, accelerated talent
Slide 8: 1) Targeting Higher-Growth, Advantaged Markets
1) Targeting Higher-Growth, Advantaged Markets 8020 Focus: Enhance portfolio through proprietary M&A and selective divesture EXAMPLES OF TARGETED, ADVANTAGED MARKETS Data Centers Space and Defense Semiconductor Water Recent Airtech and Muon Iridian, STC, Muon, Mott, Muon and Mott Nexsight and Subter
Slide 9: 2) Commercial & Operational Business Integration
2) Commercial & Operational Business Integration 8020 Focus: Integrate technologies and market access points within growth platforms Materials Science Solutions Platform MATERIALS Form critical properties Offering all three is a Operational integration competitive advantage streamlines costs, improv
Slide 10: 3) Balanced Capital Deployment
3 3) Balanced Capital Deployment 8020 Focus: Near-term, target bolt-on acquisitions and returning capital to shareholders Framework for Returns-Focused Capital Allocation M&A Dividends Share Repurchase Core to our growth Delivering reliable and Increased repurchase compounding strategy consist
Slide 11: Building High Margin Growth Platforms in Advantaged Markets
Building High Margin Growth Platforms in Advantaged Markets MEGATRENDS AI & Digitization | Regionalization & Defensive Industrialization | Reimagined Supply Chains Energy Efficiency | Demographic Shifts Fire & Safety / Health & Science Technologies Fluid & Metering Technologies Diversified Products
Slide 12: IDEX Business Overview
IDEX Business Overview 12 12
Slide 13: IDEX Business Characteristics
IDEX Business Characteristics Business Model Competitive Advantage Manufacturing focus on components, subcomponents and modules Industry leaders High criticality but small portion of High margins with room to grow customers’ bill of materials Favorable trends end market secular Asset-lig
Slide 14: Segments Summary
Segments Summary Health & Science Fluid & Metering Fire & Safety / Diversified Technologies Technologies Products $1.5B ~43% 26.6% $1.2B ~35% 33.2% $0.75B ~22% 28.7% 2025 of 2025 2025 2025 of 2025 2025 2025 of 2025 2025 Sales Segment Sales Adj. EBITDA% Sales Segment Sales Adj. EBITDA % Sales Segment
Slide 15: Segment Snapshot: Health & Science Technologies
Segment Snapshot: Health & Science Technologies Segment Revenue Reporting Units 2025 Sales Key End Markets • Life Sciences • Food & Beverage Scientific Fluidics & Optics 57% • Space & Defense • Energy 69% Performance Pneumatics Technologies 17% Other • Semiconductor Markets Sealing Solutions 17% Mat
Slide 16: Segment Snapshot: Fluid & Metering Technologies
Segment Snapshot: Fluid & Metering Technologies Reporting Units 2025 Sales Segment Revenue Key End Markets Pumps 35% • Industrial • Chemical Water 29% • Water • Agriculture 84% Other • Energy Markets Energy 17% Agriculture 11% Valves 8% Financial Performance ($M) $1,247 $1,233 $1,224 $1,167 $999 33.
Slide 17: Segment Snapshot: Fire & Safety / Diversified Products
Segment Snapshot: Fire & Safety / Diversified Products Segment Revenue Reporting Units 2025 Sales Key End Markets • Fire Suppression • Rescue Tools Fire and Safety 64% • Paint Dispensing • Automotive & Aviation 91% Other Dispensing 20% Markets • Aerospace/Defense BAND-IT 16% Financial Performance ($
Slide 18: Financial Performance
Financial Performance 18 18
Slide 19: Strong Record of Sales and Earnings Growth, Primed for Acceleration
Strong Record of Sales and Earnings Growth, Primed for Acceleration Revenue ($M) Adj. EPS* $8.12 $8.22 $7.89 $7.95 $3,458 $3,182 $3,274 $3,269 $6.87 $2,765 $6.18 $2,495 $2,352 $5.61 2019 2020 2021 2022 2023 2024 2025 2019 2020 2021 2022 2023 2024 2025 Adj. EBITDA* ($M) • 2019 – 2022 high-single-di
Slide 20: Healthy Balance Sheet and Strong Cash Generation Support Financial and Strategic Flexibility
Healthy Balance Sheet and Strong Cash Generation Support Financial and Strategic Flexibility Gross Leverage Ratio Free Cash Flow & Conversion Rate* ($M) 1 2.2x $627 $617 2.0x 101% $603 101% 103% 1.7x 1.6x 1.7x 1.5x $518 1.3x $477 131% $493 $489 94% 79% 107% 2019 2020 2021 2022 2023 2024 2025 2019 20
Slide 21: IDEX Value Drivers
IDEX Value Drivers Differentiated 8020 operating model drives full business potential through simplification, focused resourcing and streamlined execution Focused on continuously evolving our portfolio toward high-growth, advantaged markets with secular tailwinds Balanced allocator of capital with s
Slide 22: Non-GAAP Reconciliations
Non-GAAP Reconciliations 22 22
Slide 23: Reconciliations of Net Income to Adjusted EBITDA
Reconciliations of Net Income to Adjusted EBITDA For the Years Ended December 31, (dollars in millions) 2019 2020 2021 2022 2023 2024 2025 Reported net income $ 425.5 $ 377.8 $ 449.3 $ 586.7 $ 595.6 $ 504.6 $ 482.5 Provision for income taxes 107.4 92.5 130.5 162.7 164.7 134.7 150.1 Interest expense
Slide 24: Reconciliations of Reported-to-Adjusted Net Income Attributable to IDEX
Reconciliations of Reported-to-Adjusted Net Income Attributable to IDEX For the Years Ended December 31, (in millions) 2019 2020 2021 2022 2023 2024 2025 Reported net income attributable to IDEX $ 425.5 $ 377.8 $ 449.4 $ 586.9 $ 596.1 $ 505.0 $ 483.2 Fair value inventory step-up charges 3.3 4.1 11.6
Slide 25: Reconciliations of Diluted EPS Attributable to IDEX
Reconciliations of Diluted EPS Attributable to IDEX (in millions, except per share amounts) For the Years Ended December 31, 2019 2020 2021 2022 2023 2024 2025 Reported diluted EPS attributable to IDEX $ 5.56 $ 4.94 $ 5.88 $ 7.71 $ 7.85 $ 6.64 $ 6.41 Fair value inventory step-up charges 0.04 0.05 0.
Slide 26: Reconciliations of Cash Flows from Operating Activities to Free Cash Flow
Reconciliations of Cash Flows from Operating Activities to Free Cash Flow (dollars in millions) For the Years Ended December 31, 2019 2020 2021 2022 2023 2024 2025 Cash flows from operating activities $ 528.1 $ 569.3 $ 565.3 $ 557.4 $ 716.7 $ 668.1 $ 680.4 Less: Capital expenditures 50.9 51.6 72.7 6